Outcomes in heart failure patients with preserved ejection fraction
Mortality, readmission, and functional decline
Grace L. Smith, MPH*,
Frederick A. Masoudi, MD, MSPH, FACC ,
Viola Vaccarino, MD, PhD ,
Martha J. Radford, MD, FACC* || and
Harlan M. Krumholz, MD, FACC* ||¶,*
* YaleNew Haven Hospital Center for Outcomes Research and Evaluation, New Haven, Connecticut, USA
Division of Cardiology, Denver Health Medical Center, Denver, Colorado, USA
Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
|| Qualidigm, Middletown, Connecticut, USA
¶ Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA

View larger version (11K):
[in a new window]
|
Figure 1 Proportional hazards model of adjusted overall survival. EF = ejection fraction.
|
|

View larger version (27K):
[in a new window]
|
Figure 2 Death and functional status changes at follow-up.
|
|
|